Biosyent Inc. (CVE:RX) is set to announce its earnings results before the market opens on Wednesday, November 15th. Analysts expect the company to announce earnings of C$0.10 per share for the quarter.
Biosyent Inc. (RX) opened at C$10.25 on Tuesday. Biosyent Inc. has a 1-year low of C$6.90 and a 1-year high of C$11.00.
ILLEGAL ACTIVITY WARNING: “Biosyent Inc. (RX) Set to Announce Quarterly Earnings on Wednesday” was first posted by Chaffey Breeze and is the property of of Chaffey Breeze. If you are accessing this piece of content on another domain, it was illegally copied and republished in violation of United States and international trademark and copyright law. The correct version of this piece of content can be read at https://www.chaffeybreeze.com/2017/11/14/biosyent-inc-rx-set-to-announce-quarterly-earnings-on-wednesday.html.
Biosyent Company Profile
BioSyent Inc is a specialty pharmaceutical company. The Company, through its subsidiary, BioSyent Pharma Inc, acquires or in-licenses and develops pharmaceutical products for sale in Canada and certain international markets. It has four business units: the Community and Women’s Health Unit, which commercializes pharmaceutical products focused on improving family and women’s health; the Hospital Business Unit, which sells pharmaceutical products to hospitals and hospital specialists; the International Pharmaceutical Unit, and the Legacy Business.
Receive News & Ratings for Biosyent Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Biosyent Inc. and related companies with MarketBeat.com's FREE daily email newsletter.